SEC Form 4 · accession 0001209191-19-017824
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine Castellanos
Officer — Principal Accounting Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stockF1 | Mar 5, 2019 | C | 3,588 | — | A | 5,726 | D | |
| Class A common stock | Mar 5, 2019 | S | 3,588 | $102.00 | D | 2,138 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1 | $11.00 | Mar 5, 2019 | M | 3,588 | D | — | May 25, 2026 | Class B common stock | 3,588 | 43,434 | D |
| Class B common stockF1 | — | Mar 5, 2019 | M | 3,588 | A | — | — | Class A common stock | 3,588 | 3,588 | D |
| Class B common stockF1 | — | Mar 5, 2019 | C | 3,588 | D | — | — | Class A common stock | 3,588 | 0 | D |
Explanation of responses
- F1The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- F2The options vest in sixteen equal quarterly installments beginning on August 25, 2016.
Remarks
Vice President, Finance and Accounting